Breaking Barriers: The Patchwork of Global Regulations in AI, Pharmaceuticals, and Medical Devices
Last Saturday, while watching my nephew’s rugby match, a friend turned to me and said, “Have you read this? The same breakfast cereal can have different colors and ingredients depending on the country it’s sold in. Same manufacturer, and the same box, but different rules, different pricing, and different margins. This needs to change—it’s weird.” That conversation struck a chord.
The same challenge exists in pharmaceuticals, medical devices, and now, more than ever, AI-driven healthcare solutions. The fragmented landscape of global regulations is creating significant barriers to innovation and access.
